Frontlight ResearchEarly access
WithdrawnNo phase
Frailty in Individuals With Advanced Heart Failure Part 2
Key facts
- Who runs it
- University of Southern California
- Where
- Los Angeles, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 9 Nov 2021
- Ended
- 31 Dec 2023
- Type of study
- Observational, 3 groups
- Treatments tested
- LVAD or Heart Transplant
- Record updated
- 30 May 2024
- Why it stopped
- Transitioned professional responsibilities.
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Individuals will be included in this study if they were evaluated for advanced heart failure therapies at Keck Hospital from 1/1/2019-6/30/2021. This will be determined through data from the electronic medical record
Who cannot take part
- Patients who did not receive an occupational therapy evaluation prior to advanced heart failure intervention decision
Where in United States
- Keck Hospital of USCLos Angeles, United States
About the trial
What the trial wants to find out
To investigate how measures of frailty, assessed during occupational therapy (OT) evaluation and intervention impact decision for advanced heart failure (HF) therapies and postoperative outcomes.
The 3 groups in the trial
- Medical Management
Patients deemed not candidates for advanced heart failure interventions.
- Left Ventricular Assist Device (LVAD)
Recipients of a left ventricular assist device
Treatment: LVAD or Heart Transplant
- Heart Transplant
Recipients of a heart transplant.
Treatment: LVAD or Heart Transplant
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 30 May 2024